Author:
Lu Guo-Liang,Ashoorzadeh Amir,Anderson Robert F.,Patterson Adam V.,Smaill Jeff B.
Funder
Health Research Council of New Zealand
The Ministry of Business, Innovation and Employment
The Maurice Wilkins Centre for Molecular Biodiscovery
Proacta Incorporated
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference23 articles.
1. Abstract C46: Design and identification of the novel hypoxia‐activated irreversible pan‐HER inhibitor SN29966
2. Abstract A247: Mechanism of action of the hypoxia-activated irreversible pan-HER inhibitor SN29966.
3. Smaill, J. B.; Patterson, A. V.; Hay, M. P.; Denny, W. A.; Wilson, W. R.; Lu, G. -L.; Anderson, R. F.; Lee, H. H.; Ashoorzadeh, A. PCT Int. Appl. WO2010104406A1, 2010.
4. 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity
5. Hypoxia-Selective Antitumor Agents. 16. Nitroarylmethyl Quaternary Salts as Bioreductive Prodrugs of the Alkylating Agent Mechlorethamine
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献